You are here

  • Home
  • Archive
  • Volume 4, Issue 12
  • Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis

Article metrics

Article menu
XML
Diabetes and endocrinology
Research
Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 2018726011
Feb 201824623316
Mar 201811810517
Apr 20181019713
May 20181591435
Jun 201865634
Jul 2018787416
Aug 2018988914
Sep 2018807214
Oct 2018857319
Nov 20181029020
Dec 201881774
Jan 201954487
Feb 2019585013
Mar 2019373122
Apr 2019191719
May 2019564023
Jun 2019242218
Jul 2019191512
Aug 201912108
Oct 201911911
Nov 2019251918
Dec 2019292312
Jan 2020191111
Feb 2020241414
Mar 2020271912
May 202021158
Jun 202023159
Jul 2020261913
Aug 2020181414
Sep 2020222213
Oct 2020252117
Nov 2020513319
Dec 202017157
Jan 2021231814
Feb 202110810
Mar 202112104
Apr 202131226
May 202118179
Jun 202117178
Jul 2021212116
Aug 2021181814
Sep 2021313017
Oct 2021271820
Nov 2021653136
Dec 2021191910
Jan 202213137
Feb 202222185
Mar 2022262016
Apr 202220168
May 2022422416
Jun 2022342716
Jul 202225197
Aug 202227239
Sep 2022262055
Oct 2022322413
Nov 2022272313
Dec 202225215
Jan 2023282511
Feb 2023776743
Mar 202333308
Apr 2023321417
May 202313912
Jun 2023151510
Jul 2023191910
Aug 2023261616
Sep 202316144
Oct 2023221410
Nov 202314127
Dec 2023423612
Jan 2024272712
Feb 2024141412
Mar 2024221513
Apr 2024191613
Total29322478997